Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients

L Migliore1, I Fontana, F Trippi

  • 1Department of Human and Environmental Sciences, University of Pisa, Via S. Giuseppe 22, 56126 Pisa, Italy. I.migliore@geog.unipi.it

Neurobiology of Aging
|February 15, 2005
PubMed

Insights

Oxidative stress, indicated by DNA damage, is an early event in Alzheimer's disease (AD) and mild cognitive impairment (MCI) pathogenesis. This DNA damage is significantly higher in patients with MCI and AD compared to healthy individuals.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Oxidative stress is implicated in Alzheimer's disease (AD) neurodegeneration.
  • The precise role of oxidative stress as a primary trigger in AD pathogenesis remains unclear.
  • Mild cognitive impairment (MCI) represents an intermediate stage between normal aging and AD.

Purpose of the Study:

  • To investigate the levels of primary and oxidative DNA damage in patients with MCI and AD.
  • To compare DNA damage levels between MCI patients, AD patients, and healthy controls.

Main Methods:

  • Comet assay analysis was employed to assess DNA damage.
  • Leukocytes from MCI patients, AD patients, and healthy controls were analyzed.

Main Results:

  • Significantly elevated primary DNA damage was observed in leukocytes of both AD and MCI patients compared to controls.
  • Oxidized DNA bases (purines and pyrimidines) were significantly higher in AD and MCI patient groups versus controls.
  • Average primary DNA damage levels were 2.09±0.79 for AD, 2.47±1.01 for MCI, and 1.04±0.31 for controls.

Conclusions:

  • Oxidative stress, evidenced by DNA damage, appears to be an early event in the pathogenesis of Alzheimer's disease.
  • These findings suggest that DNA damage is a relevant biomarker in the progression from MCI to AD.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...